Inflammation News and Research

RSS

Black patients with lupus have higher risk of stroke and ischemic heart disease

New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.

6 Nov 2020

New guideline for juvenile idiopathic arthritis gives emphasis to disease-modifying treatments

The American College of Rheumatology will preview the 2021 Guideline for the Treatment of Juvenile Idiopathic Arthritis at ACR Convergence, the ACR's annual meeting.

6 Nov 2020

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies.

6 Nov 2020

White blood cells can be used to attack tumors after completing a special training

Scientists at the National Center for Tumor Diseases Dresden and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program - be utilized for the treatment of tumors.

6 Nov 2020

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

A new study shows that patients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of antimalarial drugs, including hydroxychloroquine, during the 2020 global coronavirus pandemic, when antimalarials were touted as a possible COVID-19 treatment.

6 Nov 2020

Survey: Only few children with rheumatic diseases report contracting COVID-19

Results from a large, international survey shows that only a small fraction of children with rheumatic diseases reported contracting COVID-19.

6 Nov 2020

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, discovers that use of hydroxychloroquine, a generic drug, does not cause any significant differences in QTc length or prolonged QTc, key measures of heart rate, in people with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE).

6 Nov 2020

Oral methotrexate can be an effective intervention for people with knee OA

A new study presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that after three months of treatment with oral methotrexate, adults with primary knee osteoarthritis (OA) with inflammation had significant improvements in physical function and inflammation, a sign that this inexpensive, generic pill may be an important intervention for knee OA.

6 Nov 2020

Corticosteroid injections for knee OA do not speed up the progression of disease

New research shows that corticosteroid injections for knee OA treatment do not hasten a patient's progression to a total knee replacement when compared with hyaluronic acid injections.

6 Nov 2020

Women with interstitial lung disease may not need to terminate their pregnancies

A new study shows that women with interstitial lung disease (ILD) related to autoimmune disease may not need to terminate their pregnancies--despite the increased risk of adverse outcomes--provided they have close monitoring from their team of multidisciplinary physicians before, during and after pregnancy.

6 Nov 2020

Rapid rise in CRP levels predicts COVID-19 outcomes

Predicting the course of a COVID-19 patient's disease after hospital admission is essential to improving treatment.

6 Nov 2020

Research describes novel molecules designed to treat or prevent COVID-19 infection

Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.

6 Nov 2020

Foods that cause inflammation tied to a higher risk of cardiovascular disease

A new study by researchers at the Harvard T.H. Chan School of Public Health has found that diets high in red and processed meat, sugary beverages, and refined grains promote inflammation in the body and increase the subsequent risk of heart disease and stroke.

5 Nov 2020

COVID-19 patients who experience strokes appear to have worse outcomes

People who experience strokes while infected with COVID-19 appear to be left with greater disability after the stroke, according a study led by UCL and UCLH researchers.

5 Nov 2020

Study investigates the ebb and flow of brain ventricles

Enlarged ventricles in the brains of people with multiple sclerosis were previously considered a sign of tissue loss.

5 Nov 2020

UCF researcher leads project to identify factors linked to preterm births among Black women

The rate of preterm births in the U.S. has been on the rise during the past six years, with a stark difference in the rate of preterm births among non-Hispanic Black women compared to non-Hispanic white women.

5 Nov 2020

Ground-breaking discovery provides new insight into how proteins operate

A ground-breaking discovery by Centenary Institute scientists has provided new understanding as to the nature of proteins and how they exist and operate in the human body.

5 Nov 2020

Researchers develop novel therapeutic approach against COPD

Chronic obstructive pulmonary disease (COPD) is one of the most common and deadliest diseases worldwide.

4 Nov 2020

Delirium accompanied by fever could be an early symptom of COVID-19

Delirium accompanied by fever could bean early symptom of COVID-19. This is the main conclusion drawn by a scientific research review carried out by researchers from the Universitat Oberta de Catalunya.

4 Nov 2020

Study sheds light on possible lung damage caused by COVID-19 virus

The study, published today in The Lancet's eBioMedicine, by King's College London in collaboration with University of Trieste and the International Centre for Genetic Engineering and Biology in Italy, shows the unique characteristics to the SARS-CoV-2 virus and may explain why patients suffer from 'long COVID'.

4 Nov 2020

Inflammation News and Research

Black patients with lupus have higher risk of stroke and ischemic heart disease

New guideline for juvenile idiopathic arthritis gives emphasis to disease-modifying treatments

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

White blood cells can be used to attack tumors after completing a special training

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

Survey: Only few children with rheumatic diseases report contracting COVID-19

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

Oral methotrexate can be an effective intervention for people with knee OA

Corticosteroid injections for knee OA do not speed up the progression of disease

Women with interstitial lung disease may not need to terminate their pregnancies

Rapid rise in CRP levels predicts COVID-19 outcomes

Research describes novel molecules designed to treat or prevent COVID-19 infection

Foods that cause inflammation tied to a higher risk of cardiovascular disease

COVID-19 patients who experience strokes appear to have worse outcomes

Study investigates the ebb and flow of brain ventricles

UCF researcher leads project to identify factors linked to preterm births among Black women

Ground-breaking discovery provides new insight into how proteins operate

Researchers develop novel therapeutic approach against COPD

Delirium accompanied by fever could be an early symptom of COVID-19

Study sheds light on possible lung damage caused by COVID-19 virus

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News